Logo image of LGCL

LUCAS GC LTD-A (LGCL) Stock Fundamental Analysis

USA - NASDAQ:LGCL - KYG570371065 - Common Stock

2.8 USD
0 (0%)
Last: 10/22/2025, 1:50:59 PM
Fundamental Rating

4

Taking everything into account, LGCL scores 4 out of 10 in our fundamental rating. LGCL was compared to 86 industry peers in the Professional Services industry. LGCL has only an average score on both its financial health and profitability. LGCL is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year LGCL was profitable.
LGCL had a positive operating cash flow in the past year.
LGCL had positive earnings in 4 of the past 5 years.
In multiple years LGCL reported negative operating cash flow during the last 5 years.
LGCL Yearly Net Income VS EBIT VS OCF VS FCFLGCL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

1.2 Ratios

LGCL has a Return On Assets of 23.14%. This is amongst the best in the industry. LGCL outperforms 97.67% of its industry peers.
With an excellent Return On Equity value of 35.51%, LGCL belongs to the best of the industry, outperforming 86.05% of the companies in the same industry.
LGCL has a Return On Invested Capital of 19.25%. This is amongst the best in the industry. LGCL outperforms 90.70% of its industry peers.
LGCL had an Average Return On Invested Capital over the past 3 years of 16.50%. This is above the industry average of 13.28%.
The 3 year average ROIC (16.50%) for LGCL is below the current ROIC(19.25%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 23.14%
ROE 35.51%
ROIC 19.25%
ROA(3y)16.75%
ROA(5y)1.76%
ROE(3y)27.94%
ROE(5y)-22.38%
ROIC(3y)16.5%
ROIC(5y)20.16%
LGCL Yearly ROA, ROE, ROICLGCL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

LGCL has a Profit Margin of 5.59%. This is in the better half of the industry: LGCL outperforms 65.12% of its industry peers.
LGCL's Profit Margin has declined in the last couple of years.
LGCL has a Operating Margin (4.86%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of LGCL has declined.
LGCL has a Gross Margin (33.58%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of LGCL has grown nicely.
Industry RankSector Rank
OM 4.86%
PM (TTM) 5.59%
GM 33.58%
OM growth 3Y-22.64%
OM growth 5YN/A
PM growth 3Y-13.43%
PM growth 5YN/A
GM growth 3Y6.97%
GM growth 5YN/A
LGCL Yearly Profit, Operating, Gross MarginsLGCL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 10 -10 20 30

More info and screens

5

2. Health

2.1 Basic Checks

LGCL has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, LGCL has about the same amount of shares outstanding.
Compared to 1 year ago, LGCL has a worse debt to assets ratio.
LGCL Yearly Shares OutstandingLGCL Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M
LGCL Yearly Total Debt VS Total AssetsLGCL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

LGCL has an Altman-Z score of 15.10. This indicates that LGCL is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 15.10, LGCL belongs to the top of the industry, outperforming 97.67% of the companies in the same industry.
A Debt/Equity ratio of 0.26 indicates that LGCL is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.26, LGCL perfoms like the industry average, outperforming 54.65% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z 15.1
ROIC/WACC2.82
WACC6.83%
LGCL Yearly LT Debt VS Equity VS FCFLGCL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

LGCL has a Current Ratio of 1.91. This is a normal value and indicates that LGCL is financially healthy and should not expect problems in meeting its short term obligations.
LGCL has a better Current ratio (1.91) than 69.77% of its industry peers.
A Quick Ratio of 1.91 indicates that LGCL should not have too much problems paying its short term obligations.
LGCL has a better Quick ratio (1.91) than 69.77% of its industry peers.
Industry RankSector Rank
Current Ratio 1.91
Quick Ratio 1.91
LGCL Yearly Current Assets VS Current LiabilitesLGCL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

2

3. Growth

3.1 Past

LGCL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -28.64%.
The Earnings Per Share has been growing slightly by 2.00% on average over the past years.
The Revenue for LGCL has decreased by -27.25% in the past year. This is quite bad
Measured over the past years, LGCL shows a quite strong growth in Revenue. The Revenue has been growing by 17.70% on average per year.
EPS 1Y (TTM)-28.64%
EPS 3Y2%
EPS 5YN/A
EPS Q2Q%-48.6%
Revenue 1Y (TTM)-27.25%
Revenue growth 3Y17.7%
Revenue growth 5YN/A
Sales Q2Q%-27.85%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LGCL Yearly Revenue VS EstimatesLGCL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 500M 1B

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 16.47, the valuation of LGCL can be described as correct.
LGCL's Price/Earnings ratio is a bit cheaper when compared to the industry. LGCL is cheaper than 68.60% of the companies in the same industry.
LGCL's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.77.
Industry RankSector Rank
PE 16.47
Fwd PE N/A
LGCL Price Earnings VS Forward Price EarningsLGCL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LGCL indicates a slightly more expensive valuation: LGCL is more expensive than 62.79% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 24.31
LGCL Per share dataLGCL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

LGCL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LGCL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LUCAS GC LTD-A

NASDAQ:LGCL (10/22/2025, 1:50:59 PM)

2.8

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)09-26 2025-09-26
Earnings (Next)03-23 2026-03-23
Inst Owners0.17%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap312.54M
Revenue(TTM)1.67B
Net Income(TTM)93.32M
AnalystsN/A
Price TargetN/A
Short Float %1.18%
Short Ratio0.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 16.47
Fwd PE N/A
P/S 1.33
P/FCF N/A
P/OCF 110.22
P/B 8.46
P/tB 8.46
EV/EBITDA 24.31
EPS(TTM)0.17
EY6.07%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.03
OCFY0.91%
SpS2.1
BVpS0.33
TBVpS0.33
PEG (NY)N/A
PEG (5Y)N/A
Graham Number1.12
Profitability
Industry RankSector Rank
ROA 23.14%
ROE 35.51%
ROCE 30.56%
ROIC 19.25%
ROICexc 21.38%
ROICexgc 21.38%
OM 4.86%
PM (TTM) 5.59%
GM 33.58%
FCFM N/A
ROA(3y)16.75%
ROA(5y)1.76%
ROE(3y)27.94%
ROE(5y)-22.38%
ROIC(3y)16.5%
ROIC(5y)20.16%
ROICexc(3y)22.18%
ROICexc(5y)107.07%
ROICexgc(3y)22.18%
ROICexgc(5y)107.07%
ROCE(3y)23.94%
ROCE(5y)27.35%
ROICexgc growth 3Y-73.82%
ROICexgc growth 5YN/A
ROICexc growth 3Y-73.82%
ROICexc growth 5YN/A
OM growth 3Y-22.64%
OM growth 5YN/A
PM growth 3Y-13.43%
PM growth 5YN/A
GM growth 3Y6.97%
GM growth 5YN/A
F-Score4
Asset Turnover4.14
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA 0.75
Cap/Depr 872.25%
Cap/Sales 4.62%
Interest Coverage 44.68
Cash Conversion 22.42%
Profit Quality N/A
Current Ratio 1.91
Quick Ratio 1.91
Altman-Z 15.1
F-Score4
WACC6.83%
ROIC/WACC2.82
Cap/Depr(3y)485.9%
Cap/Depr(5y)1067.59%
Cap/Sales(3y)3.29%
Cap/Sales(5y)3.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.64%
EPS 3Y2%
EPS 5YN/A
EPS Q2Q%-48.6%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-27.25%
Revenue growth 3Y17.7%
Revenue growth 5YN/A
Sales Q2Q%-27.85%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-31.59%
EBIT growth 3Y-8.95%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-17.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y155.44%
OCF growth 3Y-30.69%
OCF growth 5YN/A